Effect of Robot Rehabilitation Exercise Training on Motor Control After Stroke

NCT ID: NCT02331407

Last Updated: 2019-05-07

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 9 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2008-10-31
• Study Completion Date: 2011-05-31

Brief Summary

Stroke is a leading cause of neurological disability worldwide, often causing significant weakening and paresis of the affected arm. National spending on post-stroke rehabilitation is project to expand 20% to 35% through 2010. As a new tool for therapists, robotic stroke therapy devices have the potential to be a cost-effective device aid to physical therapy and enable novel modes of exercise not currently available. While recent studies have shown chronic patients benefit from repetitive practice, it is not clear whether they improved via a reduction in impairment or increased functional compensation because there is a lack of standard treatment and scales to assess rehabilitation efficacy in chronic stroke patients. This study aims to reconcile difference performance measurements in robotic rehabilitation to assess the outcome of robotic rehabilitation training.

Conditions

Stroke

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Robot arm rehabilitation therapy

Arm training using the ReoGo robotic device, 3 times a week for 3 weeks.

Group Type: EXPERIMENTAL

Robotic arm therapy

Intervention Type: DEVICE

Training with the ReoGo device

Interventions

Robotic arm therapy

Training with the ReoGo device

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

1. Hemiparesis of the upper extremity

2. Diagnosis of a first clinically apparent ischemic stroke at least 6 months prior to study entry

3. Age 18 years or older

4. Ability to sit and be active for an hour on a chair (or wheelchair) without cardiac, respiratory disturbances and/or pain.

Exclusion Criteria

1. Inability to understand and/or follow instructions

2. Pain in shoulder or arm

3. Other neurological or musculoskeletal target organ disorder

4. Inability to give informed consent personally

5. Previous or current contracture of the upper extremity

• Minimum Eligible Age: 21 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Orentreich Family Foundation

UNKNOWN

Sponsor Role: collaborator

Mailman School of Public Health

UNKNOWN

Sponsor Role: collaborator

Columbia University

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

John Krakauer, MD

Role: PRINCIPAL_INVESTIGATOR

Columbia University

Locations

Columbia Univeristy, Neurological Institute

New York, New York, United States

Countries

United States

Other Identifiers

AAAD3437

Identifier Type: -

Identifier Source: org_study_id